Advancing Spatial Biology — AACR 2025 Highlights with Chakra Chennubhotla & Arutha Kulasinghe

Join us for highlights from AACR 2025, where S. Chakra Chennubhotla, PhD (Co-Founder & Chief of AI, PredxBio) and Arutha Kulasinghe, PhD (University of Queensland) share how SpaceIQ™, our explainable AI-driven spatial multiomics platform, is uncovering new biology behind immune response and resistance in cancer. In this session, Chakra discusses how SpaceIQ™ enables robust hypothesis generation and verification, advanced cell segmentation, and emergent microdomain mapping to reveal real mechanistic insights. Arutha shares real-world clinical studies in lung, head & neck, and colorectal cancers, showing how minimal spatial biomarker signatures can predict response to checkpoint inhibitor therapy — and what this means for the future of precision oncology. 🔬 Key Topics: Hypothesis-free, unbiased spatial analytics Microdomain discovery and cell-cell communication Overcoming fibrosis barriers in immunotherapy Defining minimal multi-marker signatures Bridging discovery to clinical deployment 👉 Want to learn more? Connect with us to explore partnerships, collaborations, or to access the full data set.